Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Sep;81(2):194–202. doi: 10.1038/sj.bjc.6690677

Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts

N Matsumoto-Taniura 1, K Matsumoto 1, T Nakamura 1
PMCID: PMC2362862  PMID: 10496342

Abstract

Interactions between stromal and mammary tumour cells play a crucial role in determining the malignant behaviour of tumour cells. Although MMT mouse mammary tumour cells do not produce hepatocyte growth factor (HGF), addition of conditioned medium (CM) from MMT cells to cultures of human fibroblasts derived from skin and breast tissues stimulated the production of HGF, thereby indicating that MMT cells secrete an inducing factor for HGF. This HGF-inducing factor, purified from MMT-derived CM, proved to be prostaglandin E2 (PGE2). Consistently, treatment of MMT cells with indomethacin, an inhibitor of cyclooxygenase, abolished this HGF-inducing activity in MMT-derived CM, while treatment of MMT cells with HGF stimulated cell growth and cell motility. Likewise, HGF strongly enhanced urokinase-type plasminogen activator activity and invasion of MMT cells through Matrigel: a 15-fold stimulation in the invasion of MMT cells was seen by HGF. Finally, MMT cells in the upper compartment were co-cultivated with fibroblasts in the lower compartment of the Matrigel chamber, HGF levels in the co-culture system exceeded the level in fibroblasts alone and suppression occurred with exposure to indomethacin. Together with increase in the HGF level, the invasion of MMT cells was enhanced by co-cultivation with fibroblasts, whereas the increased invasion of MMT cells was significantly inhibited by an anti-HGF antibody and by indomethacin. These results indicate mutual interactions between MMT cells and fibroblasts: MMT-derived PGE2 plays a role in up-regulating HGF production in fibroblasts, while fibroblast-derived HGF leads to invasive growth in MMT cells. The mutual interactions mediated by HGF and prostaglandins may possibly be a mechanism regulating malignant behaviour of mammary tumour cells, through tumour–stromal interactions. © 1999 Cancer Research Campaign

Keywords: HGF; prostaglandin E2; tumour invasion; tumour–stromal interaction, mammary tumour

Full Text

The Full Text of this article is available as a PDF (200.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellusci S., Moens G., Gaudino G., Comoglio P., Nakamura T., Thiery J. P., Jouanneau J. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene. 1994 Apr;9(4):1091–1099. [PubMed] [Google Scholar]
  2. Bennett A., Stamford I. F., Berstock D. A., Dische F., Singh L., A'Hern R. P. Breast cancer, prostaglandins and patient survival. Br J Cancer. 1989 Feb;59(2):268–275. doi: 10.1038/bjc.1989.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Birchmeier C., Birchmeier W. Molecular aspects of mesenchymal-epithelial interactions. Annu Rev Cell Biol. 1993;9:511–540. doi: 10.1146/annurev.cb.09.110193.002455. [DOI] [PubMed] [Google Scholar]
  4. Bladt F., Riethmacher D., Isenmann S., Aguzzi A., Birchmeier C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature. 1995 Aug 31;376(6543):768–771. doi: 10.1038/376768a0. [DOI] [PubMed] [Google Scholar]
  5. Bussolino F., Di Renzo M. F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Comoglio P. M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992 Nov;119(3):629–641. doi: 10.1083/jcb.119.3.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Byers S., Park M., Sommers C., Seslar S. Breast carcinoma: a collective disorder. Breast Cancer Res Treat. 1994;31(2-3):203–215. doi: 10.1007/BF00666154. [DOI] [PubMed] [Google Scholar]
  7. Camps J. L., Chang S. M., Hsu T. C., Freeman M. R., Hong S. J., Zhau H. E., von Eschenbach A. C., Chung L. W. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci U S A. 1990 Jan;87(1):75–79. doi: 10.1073/pnas.87.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Colasante A., Mascetra N., Brunetti M., Lattanzio G., Diodoro M., Caltagirone S., Musiani P., Aiello F. B. Transforming growth factor beta 1, interleukin-8 and interleukin-1, in non-small-cell lung tumors. Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):968–973. doi: 10.1164/ajrccm.156.3.9701122. [DOI] [PubMed] [Google Scholar]
  9. Furlong R. A., Takehara T., Taylor W. G., Nakamura T., Rubin J. S. Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable. J Cell Sci. 1991 Sep;100(Pt 1):173–177. doi: 10.1242/jcs.100.1.173. [DOI] [PubMed] [Google Scholar]
  10. Grant D. S., Kleinman H. K., Goldberg I. D., Bhargava M. M., Nickoloff B. J., Kinsella J. L., Polverini P., Rosen E. M. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1937–1941. doi: 10.1073/pnas.90.5.1937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Grey A. M., Schor A. M., Rushton G., Ellis I., Schor S. L. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2438–2442. doi: 10.1073/pnas.86.7.2438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grobstein C. Mechanisms of organogenetic tissue interaction. Natl Cancer Inst Monogr. 1967 Sep;26:279–299. [PubMed] [Google Scholar]
  13. Jeffers M., Rong S., Vande Woude G. F. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol. 1996 Mar;16(3):1115–1125. doi: 10.1128/mcb.16.3.1115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jiang W. G., Lloyds D., Puntis M. C., Nakamura T., Hallett M. B. Regulation of spreading and growth of colon cancer cells by hepatocyte growth factor. Clin Exp Metastasis. 1993 May;11(3):235–242. doi: 10.1007/BF00121166. [DOI] [PubMed] [Google Scholar]
  15. Jin L., Fuchs A., Schnitt S. J., Yao Y., Joseph A., Lamszus K., Park M., Goldberg I. D., Rosen E. M. Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer. 1997 Feb 15;79(4):749–760. doi: 10.1002/(sici)1097-0142(19970215)79:4<749::aid-cncr12>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  16. Jin L., Yuan R. Q., Fuchs A., Yao Y., Joseph A., Schwall R., Schnitt S. J., Guida A., Hastings H. M., Andres J. Expression of interleukin-1beta in human breast carcinoma. Cancer. 1997 Aug 1;80(3):421–434. doi: 10.1002/(sici)1097-0142(19970801)80:3<421::aid-cncr10>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  17. Karmali R. A., Welt S., Thaler H. T., Lefevre F. Prostaglandins in breast cancer: relationship to disease stage and hormone status. Br J Cancer. 1983 Nov;48(5):689–696. doi: 10.1038/bjc.1983.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Konishi T., Takehara T., Tsuji T., Ohsato K., Matsumoto K., Nakamura T. Scatter factor from human embryonic lung fibroblasts is probably identical to hepatocyte growth factor. Biochem Biophys Res Commun. 1991 Oct 31;180(2):765–773. doi: 10.1016/s0006-291x(05)81131-3. [DOI] [PubMed] [Google Scholar]
  19. Lamszus K., Jin L., Fuchs A., Shi E., Chowdhury S., Yao Y., Polverini P. J., Laterra J., Goldberg I. D., Rosen E. M. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest. 1997 Mar;76(3):339–353. [PubMed] [Google Scholar]
  20. Lippman M. E., Dickson R. B. Growth control of normal and malignant breast epithelium. Prog Clin Biol Res. 1990;354A:147–178. [PubMed] [Google Scholar]
  21. Marnett L. J. Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer. Prev Med. 1995 Mar;24(2):103–106. doi: 10.1006/pmed.1995.1017. [DOI] [PubMed] [Google Scholar]
  22. Matsumoto K., Date K., Shimura H., Nakamura T. Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor. Jpn J Cancer Res. 1996 Jul;87(7):702–710. doi: 10.1111/j.1349-7006.1996.tb00281.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Matsumoto K., Matsumoto K., Nakamura T., Kramer R. H. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem. 1994 Dec 16;269(50):31807–31813. [PubMed] [Google Scholar]
  24. Matsumoto K., Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun. 1997 Oct 29;239(3):639–644. doi: 10.1006/bbrc.1997.7517. [DOI] [PubMed] [Google Scholar]
  25. Matsumoto K., Okazaki H., Nakamura T. Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration. J Biochem. 1995 Feb;117(2):458–464. doi: 10.1093/jb/117.2.458. [DOI] [PubMed] [Google Scholar]
  26. Matsunaga T., Gohda E., Takebe T., Wu Y. L., Iwao M., Kataoka H., Yamamoto I. Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway. Exp Cell Res. 1994 Feb;210(2):326–335. doi: 10.1006/excr.1994.1045. [DOI] [PubMed] [Google Scholar]
  27. Matsuzaki K., Yoshitake Y., Matuo Y., Sasaki H., Nishikawa K. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9911–9915. doi: 10.1073/pnas.86.24.9911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Montesano R., Matsumoto K., Nakamura T., Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 1991 Nov 29;67(5):901–908. doi: 10.1016/0092-8674(91)90363-4. [DOI] [PubMed] [Google Scholar]
  29. Nagy J., Curry G. W., Hillan K. J., McKay I. C., Mallon E., Purushotham A. D., George W. D. Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer. Surg Oncol. 1996 Feb;5(1):15–21. doi: 10.1016/s0960-7404(96)80017-x. [DOI] [PubMed] [Google Scholar]
  30. Nakamura T., Matsumoto K., Kiritoshi A., Tano Y., Nakamura T. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res. 1997 Aug 1;57(15):3305–3313. [PubMed] [Google Scholar]
  31. Nakamura T., Nawa K., Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 1984 Aug 16;122(3):1450–1459. doi: 10.1016/0006-291x(84)91253-1. [DOI] [PubMed] [Google Scholar]
  32. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., Tashiro K., Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989 Nov 23;342(6248):440–443. doi: 10.1038/342440a0. [DOI] [PubMed] [Google Scholar]
  33. Narisawa T., Kusaka H., Yamazaki Y., Takahashi M., Koyama H., Koyama K., Fukaura Y., Wakizaka A. Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer. Dis Colon Rectum. 1990 Oct;33(10):840–845. doi: 10.1007/BF02051919. [DOI] [PubMed] [Google Scholar]
  34. Niranjan B., Buluwela L., Yant J., Perusinghe N., Atherton A., Phippard D., Dale T., Gusterson B., Kamalati T. HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development. 1995 Sep;121(9):2897–2908. doi: 10.1242/dev.121.9.2897. [DOI] [PubMed] [Google Scholar]
  35. Ohmichi H., Koshimizu U., Matsumoto K., Nakamura T. Hepatocyte growth factor (HGF) acts as a mesenchyme-derived morphogenic factor during fetal lung development. Development. 1998 Apr;125(7):1315–1324. doi: 10.1242/dev.125.7.1315. [DOI] [PubMed] [Google Scholar]
  36. Picard O., Rolland Y., Poupon M. F. Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases. Cancer Res. 1986 Jul;46(7):3290–3294. [PubMed] [Google Scholar]
  37. Rahimi N., Tremblay E., McAdam L., Park M., Schwall R., Elliott B. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma. Cell Growth Differ. 1996 Feb;7(2):263–270. [PubMed] [Google Scholar]
  38. Rolland P. H., Martin P. M., Jacquemier J., Rolland A. M., Toga M. Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst. 1980 May;64(5):1061–1070. [PubMed] [Google Scholar]
  39. Rosen E. M., Joseph A., Jin L., Rockwell S., Elias J. A., Knesel J., Wines J., McClellan J., Kluger M. J., Goldberg I. D. Regulation of scatter factor production via a soluble inducing factor. J Cell Biol. 1994 Oct;127(1):225–234. doi: 10.1083/jcb.127.1.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Rosenberg L. Nonsteroidal anti-inflammatory drugs and cancer. Prev Med. 1995 Mar;24(2):107–109. doi: 10.1006/pmed.1995.1018. [DOI] [PubMed] [Google Scholar]
  41. Sakakura T. New aspects of stroma-parenchyma relations in mammary gland differentiation. Int Rev Cytol. 1991;125:165–202. doi: 10.1016/s0074-7696(08)61219-x. [DOI] [PubMed] [Google Scholar]
  42. Santos O. F., Barros E. J., Yang X. M., Matsumoto K., Nakamura T., Park M., Nigam S. K. Involvement of hepatocyte growth factor in kidney development. Dev Biol. 1994 Jun;163(2):525–529. doi: 10.1006/dbio.1994.1169. [DOI] [PubMed] [Google Scholar]
  43. Sasaki M., Nishio M., Sasaki T., Enami J. Identification of mouse mammary fibroblast-derived mammary growth factor as hepatocyte growth factor. Biochem Biophys Res Commun. 1994 Mar 15;199(2):772–779. doi: 10.1006/bbrc.1994.1296. [DOI] [PubMed] [Google Scholar]
  44. Seki T., Ihara I., Sugimura A., Shimonishi M., Nishizawa T., Asami O., Hagiya M., Nakamura T., Shimizu S. Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocyte. Biochem Biophys Res Commun. 1990 Oct 15;172(1):321–327. doi: 10.1016/s0006-291x(05)80212-8. [DOI] [PubMed] [Google Scholar]
  45. Seslar S. P., Nakamura T., Byers S. W. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors. Cancer Res. 1993 Mar 15;53(6):1233–1238. [PubMed] [Google Scholar]
  46. Soriano J. V., Pepper M. S., Nakamura T., Orci L., Montesano R. Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J Cell Sci. 1995 Feb;108(Pt 2):413–430. doi: 10.1242/jcs.108.2.413. [DOI] [PubMed] [Google Scholar]
  47. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 1987 May 21;327(6119):239–242. doi: 10.1038/327239a0. [DOI] [PubMed] [Google Scholar]
  48. Sykes J. A., Whitescarver J., Briggs L. Observations on a cell line producing mammary tumor virus. J Natl Cancer Inst. 1968 Dec;41(6):1315–1327. [PubMed] [Google Scholar]
  49. Tabata M. J., Kim K., Liu J. G., Yamashita K., Matsumura T., Kato J., Iwamoto M., Wakisaka S., Matsumoto K., Nakamura T. Hepatocyte growth factor is involved in the morphogenesis of tooth germ in murine molars. Development. 1996 Apr;122(4):1243–1251. doi: 10.1242/dev.122.4.1243. [DOI] [PubMed] [Google Scholar]
  50. Takahashi M., Ota S., Hata Y., Mikami Y., Azuma N., Nakamura T., Terano A., Omata M. Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach. J Clin Invest. 1996 Dec 1;98(11):2604–2611. doi: 10.1172/JCI119080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Tremblay G. Stromal aspects of breast carcinoma. Exp Mol Pathol. 1979 Aug;31(1):248–260. doi: 10.1016/0014-4800(79)90026-1. [DOI] [PubMed] [Google Scholar]
  52. Tuck A. B., Park M., Sterns E. E., Boag A., Elliott B. E. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol. 1996 Jan;148(1):225–232. [PMC free article] [PubMed] [Google Scholar]
  53. Vassalli J. D., Dayer J. M., Wohlwend A., Belin D. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J Exp Med. 1984 Jun 1;159(6):1653–1668. doi: 10.1084/jem.159.6.1653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Vassalli J. D., Pepper M. S. Tumour biology. Membrane proteases in focus. Nature. 1994 Jul 7;370(6484):14–15. doi: 10.1038/370014a0. [DOI] [PubMed] [Google Scholar]
  55. Wang Y., Selden A. C., Morgan N., Stamp G. W., Hodgson H. J. Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol. 1994 Apr;144(4):675–682. [PMC free article] [PubMed] [Google Scholar]
  56. Watson J., Chuah S. Y. Technique for the primary culture of human breast cancer cells and measurement of their prostaglandin secretion. Clin Sci (Lond) 1992 Sep;83(3):347–352. doi: 10.1042/cs0830347. [DOI] [PubMed] [Google Scholar]
  57. Weidner K. M., Arakaki N., Hartmann G., Vandekerckhove J., Weingart S., Rieder H., Fonatsch C., Tsubouchi H., Hishida T., Daikuhara Y. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7001–7005. doi: 10.1073/pnas.88.16.7001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Weidner K. M., Behrens J., Vandekerckhove J., Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol. 1990 Nov;111(5 Pt 1):2097–2108. doi: 10.1083/jcb.111.5.2097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Wernert N. The multiple roles of tumour stroma. Virchows Arch. 1997 Jun;430(6):433–443. doi: 10.1007/s004280050053. [DOI] [PubMed] [Google Scholar]
  60. Yamashita J., Ogawa M., Yamashita S., Nomura K., Kuramoto M., Saishoji T., Shin S. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res. 1994 Apr 1;54(7):1630–1633. [PubMed] [Google Scholar]
  61. Yang Y., Spitzer E., Meyer D., Sachs M., Niemann C., Hartmann G., Weidner K. M., Birchmeier C., Birchmeier W. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol. 1995 Oct;131(1):215–226. doi: 10.1083/jcb.131.1.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Yao Y., Jin L., Fuchs A., Joseph A., Hastings H. M., Goldberg I. D., Rosen E. M. Scatter factor protein levels in human breast cancers: clinicopathological and biological correlations. Am J Pathol. 1996 Nov;149(5):1707–1717. [PMC free article] [PubMed] [Google Scholar]
  63. Zarnegar R., Michalopoulos G. K. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol. 1995 Jun;129(5):1177–1180. doi: 10.1083/jcb.129.5.1177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. van den Hooff A. Stromal involvement in malignant growth. Adv Cancer Res. 1988;50:159–196. doi: 10.1016/s0065-230x(08)60437-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES